Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

Abstract

p27Kip is a candidate human tumour-suppressor protein, because it is able to inhibit cyclin-dependent kinases and block cell proliferation1,2,3,4,5. Abnormally low levels of the p27 protein are frequently found in human carcinomas, and these low levels correlate directly with both histological aggressiveness and patient mortality6,7,8,9,10. However, it has not been possible to establish a causal link between p27 and tumour suppression, because only rare instances of homozygous inactivating mations of the p27 gene have been found in human tumours11,12,13,14. Thus, p27Kip1 does not fulfil Knudson's ‘two-mutation’ criterion for a tumour-suppressor gene15. Here we show that both p27 nullizygous and p27 heterozygous mice are predisposed to tumours in multiple tissues when challenged with γ-irradiation or a chemical carcinogen. Therefore p27 is a multiple-tissue tumour suppressor in mice. Molecular analyses of tumours in p27 heterozygous mice show that the remaining wild-type allele is neither mutated nor silenced. Hence, p27 is haplo-insufficient for tumour suppression. The assumption that null mutations in tumour-suppressor genes are recessive excludes those genes that exhibit haplo-insufficiency.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Tumour-induced mortality according to p27 genotype.
Figure 2: Cumulative occurrence of specific tumour types.
Figure 3: Analysis of tumours from p27+/− mice.

Similar content being viewed by others

References

  1. Polyak, K. et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9–22 (1994).

    Article  CAS  Google Scholar 

  2. Nourse, J. et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570–573 (1994).

    Article  ADS  CAS  Google Scholar 

  3. Kato, J. Y., Matsuoka, M., Polyak, K., Massague, J. & Sherr, C. J. Cyclin AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487–496 (1994).

    Article  CAS  Google Scholar 

  4. Coats, S., Flanagan, W. M., Nourse, J. & Roberts, J. M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877–880 (1996).

    Article  ADS  CAS  Google Scholar 

  5. Fero, M. L. et al. Asyndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27kip1-deficient mice. Cell 85, 733–744 (1996).

    Article  CAS  Google Scholar 

  6. Porter, P. L. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222–225 (1997).

    Article  CAS  Google Scholar 

  7. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231–234 (1997).

    Article  CAS  Google Scholar 

  8. Esposito, V. et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 57, 3381–3385 (1997).

    CAS  PubMed  Google Scholar 

  9. Yang, R. M. et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol. 159, 941–945 (1998).

    Article  CAS  Google Scholar 

  10. Yasui, W., Kudo, Y., Semba, S., Yokozaki, H. & Tahara, E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn. J. Cancer Res. 88, 625–629 (1997).

    Article  CAS  Google Scholar 

  11. Pietenpol, J. A. et al. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res. 55, 1206–1210 (1995).

    CAS  PubMed  Google Scholar 

  12. Kawamata, N. et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res. 55, 2266–2269 (1995).

    CAS  PubMed  Google Scholar 

  13. Morosetti, R. et al. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86, 1924–1930 (1995).

    CAS  Google Scholar 

  14. Spirin, K. S. et al. p27/Kip1 mutation found in breast cancer. Cancer Res. 56, 2400–2404 (1996).

    CAS  PubMed  Google Scholar 

  15. Knudson, A. G. J Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971).

    Article  ADS  Google Scholar 

  16. Dryja, T. P. et al. Homozygosity of chromosome 13 in retinoblastoma. N. Engl. J. Med. 310, 550–553 (1984).

    Article  CAS  Google Scholar 

  17. Baker, S. J. et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244, 217–221 (1989).

    Article  ADS  CAS  Google Scholar 

  18. Kamb, A. et al. Acell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994).

    Article  ADS  CAS  Google Scholar 

  19. Harvey, M. et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5, 225–229 (1993).

    Article  CAS  Google Scholar 

  20. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).

    Article  CAS  Google Scholar 

  21. Hu, N. et al. Heterozygous Rb-1/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021–1027 (1994).

    CAS  PubMed  Google Scholar 

  22. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).

    Article  ADS  CAS  Google Scholar 

  23. Takeuchi, S. et al. Frequency loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res. 56, 738–740 (1996).

    CAS  PubMed  Google Scholar 

  24. Stegmaier, K. et al. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res. 56, 1413–1417 (1996).

    CAS  PubMed  Google Scholar 

  25. Hayette, S. et al. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias. Leukemia 11, 1696–1699 (1997).

    Article  CAS  Google Scholar 

  26. Tang, B. et al. Transforming growth factor-B1 is a new form of tumor suppressor with true haploid insufficiency. Nature Med. 4, 802–807 (1998).

    Article  CAS  Google Scholar 

  27. Bouffler, S. D., Kemp, C. J., Balmain, A. & Cox, R. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55, 3883–3889 (1995).

    CAS  PubMed  Google Scholar 

  28. Gottlieb, E. et al. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue dependent changes in radiation-induced activation during embryogenesis. EMBO J. 16, 1381–1390 (1997).

    Article  CAS  Google Scholar 

  29. Clarke, A. R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849–852 (1993).

    Article  ADS  CAS  Google Scholar 

  30. Polyak, K. et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59–66 (1994).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank P. Porter for advice on tissue pathology and K. Vo for technical assistance. This work was supported by a grant to C.J.K. from the ACS. M.L.F. is supported by the NCI and by the Jose Carreras Leukemia Foundation. J.M.R. received support from the NIH and is an Investigator of the Howard Hughes Medical Institute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher J. Kemp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fero, M., Randel, E., Gurley, K. et al. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396, 177–180 (1998). https://doi.org/10.1038/24179

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/24179

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing